| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3431d62cb61a3f65e793381f39717316 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a36f1e24fb69d3ebf96679da4fb2316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce419a113c09d7fad43030c8af609c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac0fe8b75e3daad1f37e14a02b68f66a |
| publicationDate |
2008-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2316343-C2 |
| titleOfInvention |
Method for prophylaxis of post-vaccinal complications |
| abstract |
FIELD: medicine, immunology, in particular method for prophylaxis of post-vaccinal complications in infants. n SUBSTANCE: claimed method includes determination of immunoglobulin A level in infants of one or more years old, and if said level is less than 0.25 g/l vaccination is carried out and ribomunil as administered daily for 12 days. n EFFECT: decreased complication frequency in postvaccinal period. n 3 ex, 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639128-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2616234-C1 |
| priorityDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |